Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Profile
Team
Investment Practice
Portfolio
FAQ
Download Area
News
Events
Contact Us
Text size

GLSV news

13.02.2009 Global Life Science Ventures: 2008 highlights more...

22.04.2008 GLSV receives 2007 Dyodelta European Life Science Innovation Award "Investor of the Year Award" more...

14.04.2008 April 2008 Teil 20 der Serie: Köpfe der deutschsprachigen Private Equity-Szene, Hanns-Peter Wiese, Venture Capial Magazin 4/2008 more...

17.01.2008 GLSV leads investment in Action Pharma A/S more...

06.12.2007 GLSV invests in Pelikan Technologies more...

More News


Portfolio company news

24.06.2009 Cytos Biotechnology reports biochemical findings from phase IIa study with hypertension vaccine CYT006-AngQb more...

23.06.2009 MediGene Concludes Agreement with Juste for the Commercialization of Veregen® in Spain and Portugal more...

23.06.2009 Agendia’s Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations more...

22.06.2009 NeurogesX and Astellas Enter Commercialization Agreement for Qutenza™ more...

12.06.2009 CombinatoRx Presents Full Data on Synavive Phase 2 Knee OA Trial at EULAR 2009 more...

More News